Intranasal Ion-Triggered In Situ Delivery System of Virus-like Particles: Development Using the Quality by Design Approach
Authors:
- Elena O. BakhrushinaEBElena O. Bakhrushina
- Iosif B. MikhelIMIosif B. Mikhel
- Valeriya M. KondratievaVKValeriya M. Kondratieva
- Irina M. ZubarevaIZIrina M. Zubareva
- Svetlana I. KosenkovaSKSvetlana I. Kosenkova
- Anastasiya V. BelyatskayaABAnastasiya V. Belyatskaya
- Olga I. StepanovaOSOlga I. Stepanova
- Ivan I. KrasnyukIKIvan I. Krasnyuk
- Tatyana V. GrebennikovaTatyana V. Grebennikova
- Ivan I. KrasnyukIKIvan I. Krasnyuk
Open Access
Abstract
The rapid growth in the prevalence of infectious diseases requires timely action from drug developers. In recent years, the COVID-19 pandemic has demonstrated the unpreparedness of the population for such emergencies. The introduction of modern methods of Design of Experiments (DoE) is required to accelerate the process of drug development and bring a drug to market. The main objective of this study was to develop an ion-triggered in situ system for intranasal delivery of VLP using a Quality by Design approach. Based on a literature review and initial studies, the key QTPP, CQA, CPP, and CMA were identified to develop a novel delivery system for virus-like particles. As a result of the studies on the quality attributes of the developed delivery system, an ion-triggered in situ gel meeting all the specified parameters was obtained using the Quality by Design method.Keywords
This publication has 38 references indexed in Scilit:
- Study of the effect of active pharmaceutical ingredients of various classes of BCS on the parameters of thermosensitive systems based on poloxamersSaudi Pharmaceutical Journal, 2023
- Development of In Situ Intranasal System Based on Chitosan FormateBulletin of Experimental Biology and Medicine, 2023
- Chitosan/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitisInternational Journal of Biological Macromolecules, 2022
- Stabilizing vaccines via drying: Quality by design considerationsAdvanced Drug Delivery Reviews, 2022
- Mucosal Vaccine Delivery Using Mucoadhesive Polymer Particulate SystemsTissue Engineering and Regenerative Medicine, 2021
- Rapid development and deployment of high‐volume vaccines for pandemic responseJournal of Advanced Manufacturing and Processing, 2020
- Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenanInternational Journal of Pharmaceutics, 2014
- Terminal sterilization of alginate hydrogels: Efficacy and impact on mechanical propertiesJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2013
- Physicochemical characterization and in vivo evaluation of poloxamer-based solid suppository containing diclofenac sodium in ratsInternational Journal of Pharmaceutics, 2005
- In situ gelling and mucoadhesive polymer vehicles for controlled intranasal delivery of plasmid DNAJournal of Biomedical Materials Research, 2001